🇺🇸 FDA
Patent

US 9821006

Method of producing physiological and therapeutic levels of nitric oxide through an oral delivery system

granted A61KA61K31/195A61K31/198

Quick answer

US patent 9821006 (Method of producing physiological and therapeutic levels of nitric oxide through an oral delivery system) held by The Board of Regents of the University of Texas System expires Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Nov 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/195, A61K31/198, A61K31/375, A61K31/714